A Prescription Drug User Fee Act target date of April 8, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback